Quantitative Sensory Testing and Conditioned Pain Modulation in patients after cervical percutaneous cordotomy

• Conditions: therapieresistente, oncologische pijn; cancer pain; 10027655

• Registration Number: NL-OMON42734
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

-Cervical percutaneous cordotomy, 2-4 weeks prior to the sensory testing
-The cervical percutaneous cordotomy must have been successfull: a loss of vital sensibility (determined by a positive pin-prick: a sharp pinch applied with a paper clip) caudal to dermatome C5, contralateral to the cordotomy side.
-Informed consent must have been obtained

Exclusion Criteria

-Neurological disease/ nerve conduction disorder, which will influence the results of a bilateral QST measurement
-Inability to understand and speak in dutch
-When the sensory testing will be too much of a burden for the patient (in terms of psychological capacity, logistic problems, or a very limited prognosis). The attending Anesthesiologist/Pain Specialist (P. Zomers) will determine this.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The quantitative values, obtained from the QST en CPM tests, which have been<br /><br>performed bilaterally. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable </p><br>